Silvia Puglisi Selected Research

Silvia Puglisi Research Topics

5	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 12/2022
4	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2022
4	Neoplasms (Cancer) 01/2023 - 01/2022
2	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 03/2022
2	Neoplasm Metastasis (Metastasis) 10/2023 - 06/2023
2	Disease Progression 12/2021 - 03/2016
1	Exanthema (Rash) 10/2023
1	Carcinoma (Carcinomatosis) 06/2023
1	Urologic Neoplasms (Urological Cancer) 06/2023
1	Empyema 01/2023
1	Microsatellite Instability 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Pleural Empyema (Pyothorax) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022
1	Sarcoidosis (Schaumann Disease) 08/2016

3	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2022
2	Hemoglobins (Hemoglobin)IBA 06/2023 - 01/2023
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2023
2	cabozantinibIBA 01/2023 - 01/2023
2	pazopanib FDA Link 01/2023 - 01/2023
1	Tamoxifen FDA LinkGeneric 03/2024
1	Aromatase InhibitorsIBA 03/2024
1	Hormones (Hormone)IBA 03/2024
1	Androgen Receptors (Androgen Receptor)IBA 10/2023
1	apalutamideIBA 10/2023
1	AndrogensIBA 10/2023
1	atezolizumabIBA 06/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2023
1	SteroidsIBA 06/2023
1	Proton Pump InhibitorsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	AntigensIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	GadoliniumIBA 08/2016